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Editor -We read with interest the special and insightful article by Soffin and co-workers on the 
prescription opioid crisis.1 They carefully examine many of the drivers for subsequent opioid 
dependence after surgery and provide suggestions on how practice can and should be 
improved. As proponents of enhanced recovery programmes, we acknowledge that with 
reduced postoperative length of stay, and with the increased utilisation of ambulatory/day 
surgery, patients are no longer being fully weaned off their analgesics by the time of hospital 
discharge. Thus, surgery is now a risk factor for subsequent opioid dependence, which may 
be as high as 6.5% in previously opioid naïve patients.2  
We too are concerned with the dearth of robust data to guide: the optimal type and duration of 
discharge analgesia medication; effective deprescribing strategies; and safe disposal of 
excess opioid medication with the aim of preventing both opioid dependence in the patient 
and others through illicit diversion. This lack of clarity further fuels the problem of prescribed 
postoperative opioid dependence.  
At the 6th World Congress of the Enhanced Recovery After Surgery (ERAS®) Society in May 
2018, we asked delegates to complete an online survey on postoperative opioid stewardship 
at their institution. Of the 585 international and multidisciplinary delegates, 199 returned the 
forms. Whilst 47% of the respondents felt that opioids were overprescribed in their country, 
76% of respondents’ hospitals still measured pain purely by pain intensity scales, e.g. the 
numerical pain score (NPS). Only 30% of delegates reported that their patients were explicitly 
told to avoid repeat/refill prescriptions and only 29% of the respondents’ hospitals promoted 
safe opioid disposal on discharge. The use of simple analgesics on discharge was variable, 
as was the duration of the discharge opioid prescription. Encouragingly, 36% of the 
respondents’ hospitals had a protocolised pathway for prescribing discharge medication, 
however some delegates’ institutions advocated routine use of modified/sustained-release 
opioids preparations on discharge.  
Our data further demonstrate the unwarranted variation in practice, and in order to reduce the 
burden of the prescribed opioid crisis we concur with the stance of the article that the 
durations of opioid prescriptions need to be limited, as there is substantial evidence that this 
is a risk factor for subsequent opioid dependence.3,4 We also concur that postoperative use of 
simple analgesics needs to be encouraged, both for inpatients and after discharge from 
hospital. This is because there is considerable evidence that the use of multimodal analgesia 
improves outcomes and has the dual effect of promoting functional return and simultaneously 
limits opioid consumption and their side effects.5  
In addition to the strategies identified by Soffin and colleagues,1 we recognise that the sole 
use of the numerical pain score drives opioid administration such that functional activity 
scores should be used to monitor pain and guide opioid administration.6 As 
sustained/modified-release opioid preparations have been identified as the major risk factor 
for subsequent opioid dependence,4  several North American and Antipodean organisations 
have now recommended that these preparations should not be used in the management of 
acute pain.7 Thus, there is no place for their routine use in the surgical pathway, and 
especially as part of discharge medications.7  
As there is now irrefutable evidence that once an opioid becomes a repeat/refill prescription 
the risk of subsequent opioid dependence increases,3,4 it is essential that all opioid naïve 
patients are explicitly counselled to avoid repeat/refill opioid prescriptions after discharge. If 
there is ongoing pain, alternative diagnosis and strategies must be sought and utilised.  
Recent evidence from the UK highlights that weak opioids (e.g. codeine, co-codamol) are not 
innocuous; the risk of subsequent addiction in some instances is higher with weak opioids 
than with strong opioids.8 It is, therefore, essential that patients are counselled about the 
increased risks when using these drugs, and medical practitioners need to be aware of the 
increased risks too. This study8 provides further evidence that the use of the terms strong and 
weak opioids is not appropriate in the setting of acute postoperative  
pain management, and that as perioperative physicians we should avoid the use of these 
terms. More importantly, we need to acknowledge that all opioids have the potential for 
causing subsequent opioid dependence.  
As well as the harm to the individual patient caused by subsequent opioid dependence, it is 
becoming increasingly recognised that poor opioid stewardship also leads to opioid 
diversion, and subsequent opioid dependence in the community.9  Currently, there are 
scant recommendations for safe opioid disposal once patients are discharged from hospital 
in the UK. Further social harm from opioid use/misuse arises from Drug Driving. In 2015, 
Drug Driving finally became a criminal offence in the UK, however it has been argued that 
the UK legislation is too lenient. In line with Australian guidance, UK patients should be 
advised not to drive within 4 weeks of opioid dose adjustment.10  
In summary we agree with the thrust of the review article and that further evidence is 
urgently required to guide opioid deprescribing strategies. In the meantime, in addition to 
the strategies presented by Soffin and colleagues,1 we advocate:  
• Postoperative opioid administration guided by functional activity scores, and not by the 
Numerical Pain Score.  
• Opioids prescribed to opioid naïve surgical patients should explicitly not become repeat 
prescriptions  
• The duration of the opioid prescription needs to be realistic and generally less than 5 days 
• Sustained/modified -release opioid preparations (including transdermal) should be 
avoided in the management of acute pain  
• Patients need to be given explicit advice on why and how to dispose of excess 
medication, and be informed how to taper/ wean their post-operative analgesia  
• Patients need to be warned about the dangers of drug driving.  
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